2007
DOI: 10.1016/j.lfs.2007.10.010
|View full text |Cite
|
Sign up to set email alerts
|

Role of nitric oxide/cyclic GMP/K+ channel pathways in the antinociceptive effect caused by 2,3-bis(mesitylseleno)propenol

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

2
16
0

Year Published

2010
2010
2021
2021

Publication Types

Select...
7
2

Relationship

1
8

Authors

Journals

citations
Cited by 35 publications
(18 citation statements)
references
References 51 publications
(68 reference statements)
2
16
0
Order By: Relevance
“…These findings are supported by numerous studies that determined reversion of antinociception after inhibition of the NO/ C GMP/K ATP pathway (Ortiz et al 2003;Jesse et al 2007;Hernández-Pacheco et al 2008).…”
Section: Discussionsupporting
confidence: 60%
“…These findings are supported by numerous studies that determined reversion of antinociception after inhibition of the NO/ C GMP/K ATP pathway (Ortiz et al 2003;Jesse et al 2007;Hernández-Pacheco et al 2008).…”
Section: Discussionsupporting
confidence: 60%
“…Intraplantar injection of glutamate into the mouse hindpaw produces nociceptive-like behaviors of rapid onset and short duration (about 15 min). As well as, other organoselenium compounds (Jesse et al, 2007Pavin et al, 2011;Pinto et al, 2008;Savegnago et al, 2007a,c;Wilhelm et al, 2009), the BMD reduced the nociceptive response induced by glutamate in mice. Of note, aspirin and acetaminophen demonstrated an antinociceptive effect in the glutamate test (Choi et al, 2001).…”
Section: Discussionmentioning
confidence: 89%
“…Recently, our group of research showed hepatoprotective effect of bis(4-methylbenzoyl) diselenide (BMD), an disubstituted diaryl diselenide, against carbon tetrachloride (CCl 4 )-induced oxidative damage in mice possibly by modulating the antioxidant status (Filho et al, 2013). Moreover, in previous publications, the antinociceptive and anti-inflammatory properties of organoselenium compounds were reported (Jesse et al, 2007(Jesse et al, , 2009aLuchese et al, 2010;Savegnago et al, 2006Savegnago et al, , 2007aPinto et al, 2008;Wilhelm et al, 2009;Pavin et al, 2011) which are potentially useful drugs for pain management.…”
Section: Introductionmentioning
confidence: 99%
“…There have been many reports that glibenclamide specifically blocks the ATP-sensitive K + channel, with no effects on other types of K + channel such as Ca 2+ -activated K + channel and voltage-gated potassium channels (Alves & Duarte, 2002;Jesse et al, 2007;Lazaro-Ibanez et al, 2001). In the present study, we analyzed only the participation of the K + ATP channel, but we cannot disregard the possible participation of other K + channels in the antinociceptive effect of MS.…”
Section: Discussionmentioning
confidence: 97%